new glp 1 medications Eli Lilly to seek approval of GLP-1 weight-loss drug this year What Are GLP-1 Medications? |
Description
Obesity and vitamin D deficiency: a systematic review and meta-analysis
Long-term studies are needed to validate the potential cardioprotective effects of low dose GLP-1 in generally healthy individuals What the evidence suggests: Animal studies show that low-dose GLP-1s may target hallmarks of brain aging and improve cognitive function in models of Parkinsons and Alzheimers
GLP-1R gene expression has been demonstrated in many organs and organ systems, including the heart and cardiovascular system [30]
Those are the main side effects
doi: 10.1007/s42000-018-0038-0 [DOI] [PubMed] [Google Scholar] 125
doi: 10.1172/JCI186652 47 GuarnottaVBiancoMJVigneriEPantoFLo SassoBCiaccioMet al
